Ketoropin-DT Tablet contains Ketorolac 10 mg, a potent nonsteroidal anti-inflammatory drug (NSAID) indicated for the short-term management of moderate to severe pain. Ketorolac exerts its analgesic and anti-inflammatory effects by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing the synthesis of prostaglandins, which are mediators of pain and inflammation. This tablet formulation is designed for rapid disintegration and absorption, providing effective pain relief in conditions such as postoperative pain, musculoskeletal injuries, and acute pain episodes. Ketoropin-DT is typically administered orally, with dosing tailored to the severity of pain and patient-specific factors, while ensuring the shortest effective duration to minimize adverse effects. Common side effects may include gastrointestinal discomfort, nausea, dizziness, and potential renal impairment; therefore, caution is advised in patients with a history of peptic ulcers, renal dysfunction, or cardiovascular disease. Ketorolac is contraindicated in patients with hypersensitivity to NSAIDs, active gastrointestinal bleeding, or advanced renal impairment. Due to its risk profile, Ketoropin-DT should not be used for more than five consecutive days. Monitoring for adverse reactions and appropriate dose adjustments are essential to optimize therapeutic outcomes and ensure patient safety.